Cargando…
MiR‐129‐5p promotes docetaxel resistance in prostate cancer by down‐regulating CAMK2N1 expression
This study focuses on the effect of miR‐129‐5p on docetaxel‐resistant (DR) prostate cancer (PCa) cells invasion, migration and apoptosis. In our study, the expression of CAMK2N1 was assessed by qRT‐PCR in PCa patient tissues and cell lines including PC‐3 and PC‐3‐DR. Cells transfected with miR‐129‐5...
Autores principales: | Wu, Cheng, Miao, Chunqing, Tang, Qingsheng, Zhou, Xunrong, Xi, Pengshan, Chang, Ping'an, Hua, Lixin, Ni, Haodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011149/ https://www.ncbi.nlm.nih.gov/pubmed/31876385 http://dx.doi.org/10.1111/jcmm.14050 |
Ejemplares similares
-
MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4)
por: Li, Zhengzhao, et al.
Publicado: (2019) -
MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition
por: Zhang, Yuan, et al.
Publicado: (2015) -
miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma
por: Xu, Song, et al.
Publicado: (2016) -
MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation
por: Yang, Yu, et al.
Publicado: (2015) -
Predictive values of miR-129 and miR-139 for efficacy on patients with prostate cancer after chemotherapy and prognostic correlation
por: Hu, Zhongchun, et al.
Publicado: (2019)